Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Saoussen Bacha (Ariane/Tunis, Tunisia), Saoussen Bacha, Sabrine Mejdoub, Amani Sghaier, Habibach Sonia, Hager Racil, Sana Cheikhrouhou, Naouel Chaouch, Abdellatif Chabbou, Mohamed Lamine Megdiche. Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer. Eur Respir J 2016; 48: Suppl. 60, 518

Member's Comments

No comment yet.

Related content which might interest you: The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Surgical treatmment non-small cell lung cancer in the elderly patients Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 PIWI proteins as prognostic markers in non small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016